The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novo Nordisk Limited .

Filed returns
5
match these filters
Matching filed returns per period 0 0 1 1 2 Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 2 filed returns May–Aug 2023: 1 filed returns Sep–Dec 2024: 1 filed returns 2023
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2024 Novo Nordisk Limited Health Engagement with Government regarding the life-sciences sector in Ireland and the EU General Pharmaceutical Legislation (GPL). (Public policy or programme) 6 On lobbying.ie
May–Aug 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 Novo Nordisk Limited Health To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2022 Novo Nordisk Limited Health To discuss the importance of an innovative ecosystem, including access and reimbursement environment, for a successful life science industry in Ireland to secure our place as a leading life sciences nation for the… (Public policy or programme) 3 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 5 100.0%